机译:新一代药物洗脱金属支架患者双抗血小板治疗的围手术期管理和遭受选择性的非心脏手术的生物吸收血管支架
Department of Anesthesiology Wexner Medical Center The Ohio State University;
Department of Anesthesiology Pain Medicine and Critical Care Massachusetts General Hospital;
Department of Interventional Cardiology Massachusetts General Hospital Harvard Medical School;
Department of Internal Medicine Division of Cardiovascular Medicine Wexner Medical Center The;
Department of Anesthesiology Wexner Medical Center The Ohio State University;
Department of Anesthesiology Wexner Medical Center The Ohio State University;
Duke Clinical Research Institute Duke University Medical Center;
dual-antiplatelet therapy; noncardiac surgery; stent thrombosis; metallic drug-eluting stents; bioresorbable vascular scaffolds;
机译:新一代药物洗脱金属支架患者双抗血小板治疗的围手术期管理和遭受选择性的非心脏手术的生物吸收血管支架
机译:围手术期抗血小板治疗术后患者患者患者的疗效疗效疗效治疗。
机译:冠状动脉支架植入术后接受非心脏择期手术的患者抗血小板治疗的管理建议
机译:接受主要手术患者的围手术期疼痛管理
机译:作者:张莹莹,王孝娣,王孝娣,王孝娣,王
机译:与药物洗脱和裸金属支架植入术相比生物可吸收血管支架植入术的患者概况和围手术期结局。 ORPKI波兰国家注册局的经验2014–2015
机译:在ST段抬高型心肌梗死中吸收生物可吸收的血管支架与依维莫司洗脱的金属支架:倾向评分匹配比较的1年结果BVS-EXAMINATION研究(生物可吸收的血管支架-依维莫司洗脱冠状动脉支架治疗的临床评估ST段抬高型心肌梗死患者